Perspective on This Article from The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

Authors:
  • AMAltaf Mohammed
    Altaf Mohammed
  • NJNaveena B. Janakiram
    Naveena B. Janakiram
  • QLQian Li
    Qian Li
  • VMVenkateshwar Madka
    Venkateshwar Madka
  • MEMisty Ely
    Misty Ely
  • SLStan Lightfoot
    Stan Lightfoot
  • HCHoward Crawford
    Howard Crawford
  • VSVernon E. Steele
    Vernon E. Steele
  • CRChinthalapally V. Rao
    Chinthalapally V. Rao

Abstract
Perspective on This Article from The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model